NCT05235750: Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer

NCT05235750
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be newly diagnosed (within 8 weeks) to enroll
Exclusions: 
https://ClinicalTrials.gov/show/NCT05235750

Comments are closed.

Up ↑